The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.
Tecfidera (MS) and Spinraza (Spinal Muscular Atrophy) are expected to generate big sales, while Tysabril (MS and Crohn’s Disease) and Avonex (MS) are expected to see sales drop due to
But Avonex, Plegridy, Betaferon, Rebif and Copaxone are set to be turned down. ... The appraisal rejected four other interferons - Biogen’s Avonex and long-acting variant Plegridy, Bayer’s Betaferon, and Merck Serono’s Rebif - as well as Teva’s
Zinbryta is dosed once a month - less frequently than other MS drugs such as Biogen's own Plegridy and Avonex - and is formulated as a subcutaneous injection that can be administered
2015, although older injectable MS treatment Avonex (interferon-beta-1a) fell 2% to $606m. ... Long-acting Avonex follow-up Plegridy continued to gain ground - with sales up 65% to $123m - and there were also strong gains for Biogen's haemophilia drugs
interferon products Avonex and Plegridy and lower-than-hoped-for volume growth for oral therapy Tecfidera (dimethyl glutamate). .
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...